Clinical trial
Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C…
NCT00104052 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00104052 |
|---|---|
| Title | Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1) |
| Official title | Assessment of the Safety, Efficacy, Tolerability and Pharmacokinetics of PEG-Intron® Plus REBETOL® in Pediatric Patients With Chronic Hepatitis C |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic |
| Intervention type | Biological, Drug |
| Interventions | peginterferon alfa-2b (PEG2b) (SCH 54031), ribavirin (SCH 18908) |
| Enrollment | 107 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Feb 23, 2005 |
| Last update posted | Apr 4, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: